The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

Fighting Pandemics with Plasma (The Other Kind)

Fighting Pandemics with Plasma (The Other Kind)

While researchers conduct clinical trials on use of convalescent blood serum as a therapeutic for COVID-19, there’s a very different kind of plasma that can…

NIH RADx Initiative Advances Six New COVID-19 Testing Technologies

NIH RADx Initiative Advances Six New COVID-19 Testing Technologies

The National Institutes of Health, working in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), announced on Oct. 6 a third round of…

Detecting SARS-CoV-2 in the Environment

Detecting SARS-CoV-2 in the Environment

Researchers collaborating from 7 institutions have outlined an approach to characterize and develop an effective environmental monitoring methodology for SARS CoV-2 virus, that can be…

How Pharma is Changing to Produce a Pandemic Vaccine in Rapid Time

How Pharma is Changing to Produce a Pandemic Vaccine in Rapid Time

To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor – and it needs to happen quickly. But…

The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic

The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic

Just like a fresh piece of fish, vaccines are highly perishable products and must be kept at very cold, specific temperatures. The majority of COVID-19…

COVID-19 Anti-Vaxxers Use the Same Arguments From 135 Years Ago

COVID-19 Anti-Vaxxers Use the Same Arguments From 135 Years Ago

As we get closer to an effective vaccine for COVID-19, we should expect to see a renewed push of disinformation and vocal resistance from the…

View All Featured News



HEADLINE NEWS

Convening the Emergency Committee for Ebola, Antibiotics as Infrastructure, Vaccine Confidence

Convening the Emergency Committee for Ebola, Antibiotics as Infrastructure, Vaccine Confidence

See what we’re reading this week at Global Biodefense on topics including escalating difficulties in Ebola outbreak containment and vaccine confidence plummeting in the Philippines. Contents POLICY…

DARPA Insect Allies, Dual Use Research of Concern, OPCW Hacking Plot

DARPA Insect Allies, Dual Use Research of Concern, OPCW Hacking Plot

See what we’re reading this week at Global Biodefense on topics including DARPA’s Insect Allies, new Ebola cases in eastern Congo, Dual Use Research of Concern, and…

Hepatitis E Jumps From Rats to Humans, Global AMR Challenge, Flu Season Returns

Hepatitis E Jumps From Rats to Humans, Global AMR Challenge, Flu Season Returns

See what we’re reading this week at Global Biodefense on topics including the return of flu season, pandemic candidate viruses, and the ongoing Ebola outbreak. Contents OUTBREAK…

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

Inovio, Beijing Advaccine Collaborate to Advance INO-4800 Vaccine

Inovio Pharmaceuticals, Inc. today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, Inovio’s vaccine against the recently…

AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program

AbCellera confirms that it is mobilizing its pandemic response platform against the ongoing outbreak of a novel coronavirus (2019-nCoV) originating in Wuhan, China. Since 2018, under the…

UNICEF Ships 6 Metric Tons of Supplies to Support China’s Response to Novel Coronavirus Outbreak

On 28 January 2020 in Copenhagen, Denmark, protective equipment is loaded on a truck at UNICEF’s global supply hub in Copenhagen to go to the airport where…

Bill & Melinda Gates Foundation Commits $10 Million to Global Response to 2019-nCoV

The Bill & Melinda Gates Foundation today announced that it is immediately committing $10 million in emergency funds and corresponding technical support to help frontline responders in…

Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV

Sirnaomics Inc., a leading biopharmaceutical company in discovery and development of novel RNAi therapeutics, announced today that it has mobilized its research teams both in USA and…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa